Literature DB >> 7891842

HP 749 enhances calcium-independent release of [3H]norepinephrine from rat cortical slices and synaptosomes.

C P Smith1, F P Huger, W Petko, S Kongsamut.   

Abstract

Previous studies have shown that, at concentrations of 1 microM and 10 microM, HP 749 increased electrically-stimulated release of [3H]norepinephrine (NE) from rat cortical slices. These effects were Ca(2+)-dependent, indicating an effect on release from vesicular stores. At 100 microM, HP 749 had two effects. In addition to enhancing the Ca(2+)-dependent electrically-evoked release, it also induced a rise in the basal efflux (spontaneous release) of [3H]NE, which was observed in both cortical slices and synaptosomes. The spontaneous release effect was (1) not blocked by the reuptake inhibitor nomifensine, (2) not affected by removal of external calcium, (3) not blocked by vesicular depletion with reserpine, and (4) not inhibited by the sodium channel blocker tetrodotoxin (TTX). As would be expected, the spontaneous [3H]NE release induced by the cytoplasmic releaser tyramine and the sodium channel activator veratridine were blocked by nomifensine and TTX, respectively. Notably, however, the Ca(2+)-independent veratridine-induced release was completely blocked by 100 microM HP 749. The mechanism of spontaneous release of [3H]NE caused by 100 microM HP 749 is unresolved at present; however, the data are consistent with this release originating from a cytoplasmic source.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891842     DOI: 10.1007/bf01006816

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

1.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

Authors:  M Raiteri; F Cerrito; A M Cervoni; G Levi
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

2.  Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes.

Authors:  M Raiteri; R del Carmine; A Bertollini
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

3.  Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.

Authors:  A M Palmer; P T Francis; D M Bowen; J S Benton; D Neary; D M Mann; J S Snowden
Journal:  Brain Res       Date:  1987-06-30       Impact factor: 3.252

4.  [3H]noradrenaline release from brain slices induced by an increase in the intracellular sodium concentration: role of intracellular calcium stores.

Authors:  A N Schoffelmeer; A H Mulder
Journal:  J Neurochem       Date:  1983-03       Impact factor: 5.372

5.  Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.

Authors:  A J Cross; T J Crow; E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

6.  Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.

Authors:  E M Parker; L X Cubeddu
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

7.  Idazoxan, an alpha-2 antagonist, facilitates memory retrieval in the rat.

Authors:  S J Sara; V Devauges
Journal:  Behav Neural Biol       Date:  1989-05

8.  External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation.

Authors:  E S Vizi; G T Somogyi; L G Harsing; I Zimanyi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Scopolamine-disruption of radial arm maze performance: modification by noradrenergic depletion.

Authors:  M W Decker; M Gallagher
Journal:  Brain Res       Date:  1987-08-04       Impact factor: 3.252

10.  Ouabain-evoked norepinephrine release from intact rat sympathetic neurons: evidence for carrier-mediated release.

Authors:  K J Sweadner
Journal:  J Neurosci       Date:  1985-09       Impact factor: 6.167

View more
  2 in total

1.  Serotonergic activity of HP 184: does spontaneous release have a role?

Authors:  C P Smith; A T Woods-Kettelberger; R Corbett; S M Chesson; G M Bores; W W Petko; J E Roehr; S Kongsamut
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

2.  Effects of besipirdine at the voltage-dependent sodium channel.

Authors:  L Tang; C P Smith; F P Huger; S Kongsamut
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.